Open Internet by MindsNet

Choosing the Best Path for Biotech BD/Strategy Exits

The author is uncertain which path, Healthcare Investment Banking or MBB/T2 consulting, will set them up best for a senior-level exit in business development/portfolio strategy/IR at a precision medicine or AI biotech startup.

Social Sciences, Education, Higher Education